Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

3,494

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

July 31, 2006

Conditions
ThromboembolismArthroplasty, Replacement, Hip
Interventions
DRUG

dabigatran etexilate

daily dose 150 mg once daily, half a dose on the day of surgery

DRUG

dabigatran etexilate

daily dose 150 mg once daily, half a dose on the day of surgery

DRUG

enoxaparin

40 mg once daily

Trial Locations (116)

Unknown

1160.48.06108 Canberra Hospital, Garren

1160.48.06106 St George Public Hospital, Kogarah

1160.48.06110 Suite 13 level 4, Lismore

1160.48.06105 Flinders Medical Centre, Bedford Park

1160.48.06104 Ecru, Box Hill

1160.48.06102 Monash Medical Centre, Clayton

1160.48.06101 Emeritus Research, Malvern

1160.48.06103 Maroondah Hospital, Ringwood East

1160.48.06113, Windsor

1160.48.06111 Haemophillia & Thrombosis Service, Perth

1160.48.04304 Boehringer Ingelheim Investigational Site, Linz

1160.48.04302 Boehringer Ingelheim Investigational Site, Vienna

1160.48.04303 Boehringer Ingelheim Investigational Site, Wels

1160.48.04301 Boehringer Ingelheim Investigational Site, Wiener Neustadt

1160.48.03207 UVC Brugmann, Brussels

1160.48.03206 Campus Sint-Lucas, Ghent

1160.48.03208 UZ Gent, Ghent

1160.48.03202 Boehringer Ingelheim Investigational Site, Hasselt

1160.48.03203 AZ Sint Elisabeth, Herentals

1160.48.03205 Ziekenhuis Oost-Limburg, Lanaken

1160.48.03201 UZ Gasthuisberg, Leuven

1160.48.42004 Boehringer Ingelheim Investigational Site, Brno-Bohunice

1160.48.42010 Boehringer Ingelheim Investigational Site, Chomutov

1160.48.42009 Boehringer Ingelheim Investigational Site, Havlíčkův Brod

1160.48.42008 Boehringer Ingelheim Investigational Site, Jihlava

1160.48.42002 Boehringer Ingelheim Investigational Site, Kladno

1160.48.42006 Boehringer Ingelheim Investigational Site, Kolín

1160.48.42003 Boehringer Ingelheim Investigational Site, Ostrava

1160.48.42001 Boehringer Ingelheim Investigational Site, Pilsen

1160.48.42007 Boehringer Ingelheim Investigational Site, Pradubice

1160.48.42005 Boehringer Ingelheim Investigational Site, Prague

1160.48.04571 Boehringer Ingelheim Investigational Site, Hellerup

1160.48.04570 Boehringer Ingelheim Investigational Site, Hørsholm

1160.48.04573 Boehringer Ingelheim Investigational Site, København NV

1160.48.04574 Boehringer Ingelheim Investigational Site, København S

1160.48.04575 Boehringer Ingelheim Investigational Site, Silkeborg

1160.48.35803 Boehringer Ingelheim Investigational Site, Helsinki

1160.48.35802 Boehringer Ingelheim Investigational Site, Jyväskylä

1160.48.35801 Boehringer Ingelheim Investigational Site, Oulu

1160.48.35804 Boehringer Ingelheim Investigational Site, Seinäjoki

1160.48.35805 Boehringer Ingelheim Investigational Site, Tampere

1160.48.03304 Boehringer Ingelheim Investigational Site, Amiens

1160.48.03303 Boehringer Ingelheim Investigational Site, Roubaix

1160.48.03302 Boehringer Ingelheim Investigational Site, Soyaux

1160.48.03308 Boehringer Ingelheim Investigational Site, Strasbourg

1160.48.04906 Caritaskrankenhaus, Bad Mergentheim

1160.48.04910 F.-A.-Universität Erlangen-Nürnberg, Erlangen

1160.48.04904 Orthopädische Universitätsklinik, Frankfurt

1160.48.04902 Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen

1160.48.04914 St. Bernhard-Hospital, Kamp-Lintfort

1160.48.04907 Johannes Gutenberg-Universität Mainz, Mainz

1160.48.04912 Orthopädische Klinik Markgröningen gGmbH, Markgröningen

1160.48.04901 Kreiskrankenhaus, Rheinfelden

1160.48.04915 Orthopädische Klinik Lindenlohe, Schwandorf in Bayern

1160.48.04903 Hellmuth-Ulrici-Kliniken, Sommerfeld

1160.48.04905 Aukammklinik, Wiesbaden

1160.48.03607 Boehringer Ingelheim Investigational Site, Békéscsaba

1160.48.03603 Boehringer Ingelheim Investigational Site, Budapest

1160.48.03606 Boehringer Ingelheim Investigational Site, Budapest

1160.48.03601 Boehringer Ingelheim Investigational Site, Gyula

1160.48.03604 Boehringer Ingelheim Investigational Site, Kecskemét

1160.48.03602 Boehringer Ingelheim Investigational Site, Szeged

1160.48.03605 Boehringer Ingelheim Investigational Site, Székesfehérvár

1160.48.03903 Boehringer Ingelheim Investigational Site, Bergamo

1160.48.03904 Boehringer Ingelheim Investigational Site, Bologna

1160.48.03902 Boehringer Ingelheim Investigational Site, Milan

1160.48.03901 Boehringer Ingelheim Investigational Site, Pavia

1160.48.03102 Boehringer Ingelheim Investigational Site, Amsterdam

1160.48.03101 Boehringer Ingelheim Investigational Site, Heemstede

1160.48.03107 Boehringer Ingelheim Investigational Site, Helmond

1160.48.03103 Boehringer Ingelheim Investigational Site, Hilversum

1160.48.03104 Boehringer Ingelheim Investigational Site, Nijmegen

1160.48.03105 Boehringer Ingelheim Investigational Site, Sittard

1160.48.04703 Boehringer Ingelheim Investigational Site, Ålesund

1160.48.04701 Boehringer Ingelheim Investigational Site, Bodø

1160.48.04704 Boehringer Ingelheim Investigational Site, Bærum Postterminal

1160.48.04707 Boehringer Ingelheim Investigational Site, Bærum Postterminal

1160.48.04706 Boehringer Ingelheim Investigational Site, Elverum

1160.48.04702 Boehringer Ingelheim Investigational Site, Skien

1160.48.04810 Boehringer Ingelheim Investigational Site, Bialystok

1160.48.04804 Boehringer Ingelheim Investigational Site, Kielce

1160.48.04806 Boehringer Ingelheim Investigational Site, Krakow

1160.48.04807 Boehringer Ingelheim Investigational Site, Krakow

1160.48.04812 Boehringer Ingelheim Investigational Site, Krakow

1160.48.04820 Boehringer Ingelheim Investigational Site, Lodz

1160.48.04814 Boehringer Ingelheim Investigational Site, Mielec

1160.48.04808 Boehringer Ingelheim Investigational Site, Piekary Śląskie

1160.48.04817 Boehringer Ingelheim Investigational Site, Rzeszów

1160.48.04801 Boehringer Ingelheim Investigational Site, Warsaw

1160.48.04802 Boehringer Ingelheim Investigational Site, Warsaw

1160.48.04803 Boehringer Ingelheim Investigational Site, Warsaw

1160.48.02701 Boehringer Ingelheim Investigational Site, Bryanston

1160.48.02704 Boehringer Ingelheim Investigational Site, Johannesburg

1160.48.02703 Boehringer Ingelheim Investigational Site, Randburg

1160.48.02702 Boehringer Ingelheim Investigational Site, Sandton

1160.48.03405 Boehringer Ingelheim Investigational Site, Alcorcón (Madrid)

1160.48.03403 Boehringer Ingelheim Investigational Site, Barcelona

1160.48.03411 Boehringer Ingelheim Investigational Site, Barcelona

1160.48.03407 Boehringer Ingelheim Investigational Site, Hospitalet (Barcelona)

1160.48.03409 Boehringer Ingelheim Investigational Site, Jaén

1160.48.03401 Boehringer Ingelheim Investigational Site, Madrid

1160.48.03402 Boehringer Ingelheim Investigational Site, Madrid

1160.48.03404 Boehringer Ingelheim Investigational Site, Madrid

1160.48.03406 Boehringer Ingelheim Investigational Site, Madrid

1160.48.03408 Boehringer Ingelheim Investigational Site, Móstoles (Madrid)

1160.48.03410 Boehringer Ingelheim Investigational Site, Valencia

1160.48.04602 Boehringer Ingelheim Investigational Site, Falköping

1160.48.04601 Boehringer Ingelheim Investigational Site, Gothenburg

1160.48.04607 Boehringer Ingelheim Investigational Site, Halmstad

1160.48.04606 Boehringer Ingelheim Investigational Site, Kalmar

1160.48.04603 Boehringer Ingelheim Investigational Site, Kungälv

1160.48.04608 Boehringer Ingelheim Investigational Site, Lidköping

1160.48.04605 Boehringer Ingelheim Investigational Site, Linköping

1160.48.04604 Boehringer Ingelheim Investigational Site, Mölndal

1160.48.04610 Boehringer Ingelheim Investigational Site, Stockholm

1160.48.04609 Boehringer Ingelheim Investigational Site, Varberg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY